Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Schechter

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Journal of the International AIDS Society|February 14, 2018
Prioritization of antiretroviral therapy in patients with high CD4 counts, and retention in care: lessons from the START and Temprano trialsMauro Schechter
AIDS (London, England)|September 25, 2007
Treatment at scale in Brazil: a physician's perspectiveMauro Schechter
Vaccine|May 2, 2002
HIV vaccine evaluation center in Rio de Janeiro, BrazilMauro Schechter
The Journal of Infectious Diseases|August 21, 2004
Therapy for early HIV infection: how far back should the pendulum swing?Mauro Schechter
AIDS Research and Human Retroviruses|May 22, 2012
Late diagnosis of HIV infection in Brazil despite over 15 years of free and universal access to treatmentMauro Schechter, Antonio G Pacheco
Expert Opinion on Investigational Drugs|April 28, 2007
Monotherapy with lopinavir/ritonavirMauro Schechter, Estevão Portela Nunes
The Journal of Antimicrobial Chemotherapy|July 21, 2006
Discordant immunological and virological responses to antiretroviral therapyMauro Schechter, Suely Hiromi Tuboi
Current HIV/AIDS Reports|May 26, 2010
Monitoring antiretroviral therapy in resource-limited settings: balancing clinical care, technology, and human resourcesMina C Hosseinipour, Mauro Schechter
The Journal of Antimicrobial Chemotherapy|March 12, 2011
The DART trial: 'The doctor's dilemma' revisitedEstevão Portela Nunes, Beatriz Grinsztejn, Mauro Schechter
Plos Computational Biology|December 29, 2015
Modeling the Slow CD4+ T Cell Decline in HIV-Infected IndividualsSunpeng Wang, Patricia Hottz, Mauro Schechter, et al.
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Journal of the International AIDS Society|February 14, 2018
Prioritization of antiretroviral therapy in patients with high CD4 counts, and retention in care: lessons from the START and Temprano trialsMauro Schechter
AIDS (London, England)|September 25, 2007
Treatment at scale in Brazil: a physician's perspectiveMauro Schechter
Vaccine|May 2, 2002
HIV vaccine evaluation center in Rio de Janeiro, BrazilMauro Schechter
The Journal of Infectious Diseases|August 21, 2004
Therapy for early HIV infection: how far back should the pendulum swing?Mauro Schechter
AIDS Research and Human Retroviruses|May 22, 2012
Late diagnosis of HIV infection in Brazil despite over 15 years of free and universal access to treatmentMauro Schechter, Antonio G Pacheco
Expert Opinion on Investigational Drugs|April 28, 2007
Monotherapy with lopinavir/ritonavirMauro Schechter, Estevão Portela Nunes
The Journal of Antimicrobial Chemotherapy|July 21, 2006
Discordant immunological and virological responses to antiretroviral therapyMauro Schechter, Suely Hiromi Tuboi
Current HIV/AIDS Reports|May 26, 2010
Monitoring antiretroviral therapy in resource-limited settings: balancing clinical care, technology, and human resourcesMina C Hosseinipour, Mauro Schechter
The Journal of Antimicrobial Chemotherapy|March 12, 2011
The DART trial: 'The doctor's dilemma' revisitedEstevão Portela Nunes, Beatriz Grinsztejn, Mauro Schechter
Plos Computational Biology|December 29, 2015
Modeling the Slow CD4+ T Cell Decline in HIV-Infected IndividualsSunpeng Wang, Patricia Hottz, Mauro Schechter, et al.
Pageof 14